Edmond DE Rothschild Holding S.A. Buys 173,900 Shares of DENTSPLY SIRONA Inc. $XRAY

Edmond DE Rothschild Holding S.A. grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.0% during the 2nd quarter, HoldingsChannel reports. The fund owned 3,087,300 shares of the medical instruments supplier’s stock after purchasing an additional 173,900 shares during the quarter. DENTSPLY SIRONA comprises 0.8% of Edmond DE Rothschild Holding S.A.’s holdings, making the stock its 26th biggest position. Edmond DE Rothschild Holding S.A.’s holdings in DENTSPLY SIRONA were worth $49,026,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of XRAY. Vanguard Group Inc. raised its position in shares of DENTSPLY SIRONA by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock worth $309,864,000 after purchasing an additional 557,329 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in DENTSPLY SIRONA by 11.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock worth $208,590,000 after buying an additional 1,412,517 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in shares of DENTSPLY SIRONA by 4.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock worth $180,445,000 after buying an additional 538,531 shares in the last quarter. AQR Capital Management LLC grew its holdings in shares of DENTSPLY SIRONA by 119.4% during the first quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock valued at $93,423,000 after buying an additional 3,453,662 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its position in shares of DENTSPLY SIRONA by 827.3% during the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after acquiring an additional 2,172,343 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on XRAY. Stifel Nicolaus set a $13.00 price objective on DENTSPLY SIRONA in a research report on Thursday, November 6th. Evercore ISI lowered their price target on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a report on Friday, November 7th. Barrington Research decreased their target price on DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Two investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $16.08.

DENTSPLY SIRONA Stock Up 1.4%

DENTSPLY SIRONA stock opened at $10.73 on Tuesday. DENTSPLY SIRONA Inc. has a one year low of $9.85 and a one year high of $20.59. The stock has a fifty day moving average of $12.23 and a 200 day moving average of $14.23. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The stock has a market cap of $2.14 billion, a PE ratio of -2.26, a price-to-earnings-growth ratio of 0.81 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.08). The firm had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.